Retrospective cohort study of subsequent primary cancer diagnosis among patients with neuroendocrine tumors

Neuroendocrine tumors (NETs) are heterogeneous malignant tumors with a rising incidence and are often associated with prolonged survival, making subsequent primary cancers (SPCs) an important consideration. A retrospective cohort study using the SEER database (2000-2021) evaluated the risk of SPCs among patients with a NET diagnosis. The analytic cohort included 95 625 patients with NET (52.87% female) of whom 20 119 (21.04%) had early-onset NETs (diagnosed before age 50 years). Over a median follow-up of 47 months, 7086 patients (7.41%) developed SPCs. SPCs occurred in 999 patients (4.97%) with early-onset NETs compared with 6087 patients (8.06%) with average-onset NETs. Early-onset NET was associated with a lower subdistribution hazard of SPC that attenued with increasing follow-up. Compared with average-onset NET, adjusted time-specific sHRs were 0.35 ((5% CI 0.30-0.41) at 1 year; 0.50 (0.46-0.54) at 3 years, 0.59 (0.55-0.63) at 5 years, and0.73 (0.67-0.80) at 10 years. Primary site distribution differed by age, with appendiceal NETs more common among younger than older patients, and lung/bronchus and small-intestinal NETs less common among patients younger than 50 years versus older patients. Within the early-onset cohort, male sex was associated with lower SPC risk (sHR 0.84; 95% CI 0.74-0.95). Gastric (sHR 2.60; 95% CI 2.14-3.17), pancreatic (1.47; 1,18-1.83), and small-intestinal (1.33; 1.09-1.63) NETs were associated with higher risk, and appendiceal NETs (0.73; 0.56-0.94) were associated with lower risk. The authors conclude that early-onset NETs were associated with significantly lower overall SPC hazards, with substantial heterogeneity in risk.